Learn About Pineocytoma

What is the definition of Pineocytoma?
A Pineocytoma is a tumor of the pineal gland, a small organ in the brain that makes melatonin (a sleep-regulating hormone). Signs and symptoms of Pineocytomas include headaches, nausea, hydrocephalus, vision abnormalities, and Parinaud syndrome. Pineocytomas are usually slow-growing and rarely spread to other parts of the body.
What are the alternative names for Pineocytoma?
  • Pineocytoma
  • Pinealocytoma
  • Pinealoma
Who are the top Pineocytoma Local Doctors?
Elite in Pineocytoma
Radiation Oncology
Elite in Pineocytoma
Radiation Oncology

University Of California San Francisco

400 Parnassus Ave, Mcb300, 
San Francisco, CA 
Languages Spoken:
English
Offers Telehealth

David Raleigh is a Radiation Oncologist in San Francisco, California. Dr. Raleigh is rated as an Elite provider by MediFind in the treatment of Pineocytoma. His top areas of expertise are Meningioma, Pineocytoma, Brain Tumor, and Gliomatosis Cerebri.

Elite in Pineocytoma
Elite in Pineocytoma
Helsinki, FI 

Joham Velasquez-Choque practices in Helsinki, Finland. Velasquez-Choque is rated as an Elite expert by MediFind in the treatment of Pineocytoma. Their top areas of expertise are Pineocytoma, Vein of Galen Aneurysm, Rathke Cleft Cyst, Nerve Decompression, and Extracranial-Intracranial Bypass Surgery.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Pineocytoma
Elite in Pineocytoma

Hospices Civils De Lyon

Bron, FR 

Alexandre Vasiljevic practices in Bron, France. Mr. Vasiljevic is rated as an Elite expert by MediFind in the treatment of Pineocytoma. His top areas of expertise are Pineocytoma, Pituitary Tumor, Hypothalamic Tumor, and Brain Tumor.

What are the latest Pineocytoma Clinical Trials?
Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)

Summary: This is an open-label phase 1 safety and feasibility study that will employ multi-tumor antigen specific cytotoxic T lymphocytes (TSA-T) directed against proteogenomically determined personalized tumor-specific antigens (TSA) derived from a patient's primary brain tumor tissues. Young patients with embryonal central nervous system (CNS) malignancies typically are unable to receive irradiation due ...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Phase I Clinical Trial of GPC2 Chimeric Antigen Receptor T (GPC2-CAR T) Cells for Relapsed or Refractory Medulloblastoma in Children and Young Adults

Summary: This is a single-site, open-label Phase 1 clinical trial evaluating the feasibility, safety, and preliminary activity of autologous GPC2-targeted chimeric antigen receptor (CAR) T cells administered via intracerebroventricular (ICV) infusion in children and young adults with relapsed or refractory medulloblastoma or other eligible Central Nervous System (CNS) embryonal tumors.

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center